CCCharity

Posts

Showing posts from May, 2018

rss

Government minister Lord Prior visits The London Cancer Hub

Exercise, Healthy Eating, Fat, and Cancer

Counseling Improves Survivorship Plan Implementation for Low-Income Breast Cancer Survivors

New manuscript publication on early-age onset CRC announced: Recommendations include lowering screening initiation to 45 years.

Pioneering imaging tech measures cell changes in melanoma

About the Early Age Onset Update

Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS

American Cancer Society Releases Updated Screening Guidelines

FDA Grants Brigatinib Accelerated Approval for Metastatic Non-Small Cell Lung Cancer

Experimental Cancer Drug Metarrestin Targets Metastatic Tumors

New targeted cancer drug shows signs of effectiveness in first clinical trial

ASCO 18: What to Expect in Colorectal Cancer Research

The ICR named UK’s top higher education institution for commercial earnings

TWO THIRDS OF SCOTTISH HEALTH BOARDS IN BREACH OF WAITING TIME TARGET FOR BOWEL CANCER TESTS AS SERVICES REACH CRISIS POINT

Regorafenib Becomes First FDA-Approved Drug for Liver Cancer in Nearly a Decade

Scottish Government announce new clinical diagnostics lead

How we’re commercialising a pioneering cancer drug

Study Identifies Genetic Mutations in Tumors From 10,000 Patients with Metastatic Cancer

Innovation in research provides benefits to society and the economy… but how do we measure it?

New on NCI’s Websites for May 2017

Why we study inherited cancer risk

Midostaurin Approved by FDA for Acute Myeloid Leukemia

Special device facilitates imaging of mice on clinical MRI scanners for neuroblastoma research

How our cancer tech is fighting drug resistance

HPV Vaccination Linked to Decreased Oral HPV Infections

Dabrafenib–Trametinib Combination Approved for Melanoma, Anaplastic Thyroid Cancer

Acclaimed opera singers come together to support the ICR

FDA Expands Approval of Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer

Two Nashville events to raise funds for Fight Colorectal Cancer this June

Can Immunotherapy Succeed in Glioblastoma?

Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer, Study Shows

World Cancer Research Fund launch new report on cancer risk

Some Children with Wilms Tumor Can Receive Less Therapy, Study Suggests

FDA Approves Second CAR T-Cell Therapy for Lymphoma

Premenopausal breast cancer – the challenge of research to help young women

New blood test detects early resistance to BRCA-targeting drugs for breast and ovarian cancer

ICR responds to Government report produced following Accelerated Access Review

Childhood cancer fundraiser named NHS Hero for supporting ICR research

Could childhood leukaemia become a thing of the past?

NEW REPORT: Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer

Leading UK scientist reveals likely cause of childhood leukaemia

Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer

Prime Minister announces funding for AI to help with early diagnosis for cancer

CAR T Cells: Expanding into Multiple Myeloma

Genomic Study Seeks Clues to Help Explain Breast Cancer Disparities

Trastuzumab Emtansine Improves Survival in Previously Treated Metastatic HER2-Positive Breast Cancer

What difference will the Accelerated Access Review make for cancer patients?

More breast cancer patients should be offered BRCA gene testing, new research shows

NCRI 2017: World-class research on show in Liverpool

Fight CRC Advocate, Trish Lannon Featured on Health Central

Major study gives vital new understandings of how cells divide

When normal is the favoured type

Background: Darwin’s branching tree of evolutionary phylogeny

Abiraterone Improves Survival for Some Men with Hormone-Sensitive Prostate Cancer

Background: The principles of evolutionary natural selection in cancer

Background: What has evolution got to do with cancer?

FDA Approves Pembrolizumab for Tumors with Specific Genetic Features

Time for a new perspective on cancer?

Fight CRC Advocate Walking 2,800 Miles Across The U.S. To Raise Awareness

Understanding the mutations that drive myeloma, a cancer of the bone marrow

FDA Expands Approval of Ceritinib for ALK-Positive Non-Small Cell Lung Cancer

Faces of Blue: Kendra Hunt